Background: Catheter ablation (CA) for atrial fibrillation (AF) reduced the risk of all-cause death or heart failure (HF) hospitalization among patients with HF with reduced ejection fraction (HFrEF) in the CASTLE-AF randomized trial. The trends in utilization of CA for AF in the setting of HFrEF before and after CASTLE-AF and whether disparities in CA by race have changed over time have not been well studied. Methods: Patients with AF and HFrEF from the GWTG-AF registry from 1/2016-6/2022 were included. Temporal trends in AF ablation in the overall cohort and across self-reported race-ethnicity groups (Black, White, and other) were examined using linear regression models with generalized estimating equations accounting for within-hospital clustering. Change in ablation rates following the CASTLE-AF publication (2/1/2018) were assessed using interrupted time-series analysis with linear splines with knots at the time of publication. Results: Overall, 26,678 patients (71.3±12.6 years, 45.4% Female, CHADS-VASc 1.3±0.6, 80.4% White) were included in the cohort. In the pre-Castle-AF period ablation rates were 5.2% with significantly lower rates of ablation in Black and other race patients compared with White patients (2.6% vs. 3.0% vs. 5.8%, respectively). The rates of CA increased post-CASTLE-AF (overall: 21.8%) and for each race group (Black: 20.3%, White: 22.6%, Other: 16.8%; Figure ) without significant difference in rate of increase across race groups (P-interaction for time*race = 0.82). Older age, female sex, non-White race, higher CHADS-VASc, and bleeding history were associated with less CA, while history of hypertension, obstructive sleep apnea, and the post-CASTLE-AF time period were associated with more CA. Conclusion: CA rates significantly increased post-CASTLE-AF among the entire cohort and across all race-ethnicity groups, however, non-White race was associated with lower utilization of CA over the entire period.
Read full abstract